Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

NervGen Pharma: Proof that NVG-291 works?

It’s arguably a Eureka moment for investors in NervGen Pharma (TSX.V: NGEN) (OTCQB: NGENF). Tantalizing anecdotal “evidence” has just been published that suggests that NervGen’s prospective wonder-drug — NVG-29...

Brianne Gardner's 2025 stock picks

As you will see in the full video above, Brianne Gardner , senior wealth manager at Velocity Investments, Raymond James Canada reviews her past picks from September to see if they are on the money and she gives three new diversified picks for 2025 in healthcare, ener...

dynaCERT: Growth Rocket 2025 – Why It’s in the Spotlight

As 2024 draws to a close, it is worth considering new investments for the future. A successful investment in the technology sector requires a sound strategy, thorough research, and an understanding of the ins and outs of the industry. We have summarized key points for in...

BoC’s Double Rate Cut: Is it a benefit for Canadians

The Bank of Canada (BoC) has implemented a 50-basis-point interest rate cut. This is in responds to a weakening labor market and a 5-year bond yield drop to 2.8%. With unemployment at 6.8%—its highest since 2017 (excluding pandemic years)—the move aims to stimulate the ec...

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...

Lithium and copper demand set to grow in 2025

Lithium has already seen a rise in price since the U.S. presidential election and analysts predict a huge demand for copper . Grid Battery Metals (TSXV:CELL) has lithium projects in Nevada and a Copper in British Columbia and the company’s CEO, Tim Fer...

Buzz on the Bullboards: Stocks to watch in volatile times.

This week, Canada’s main stock index, the TSX , hit another record high, supported by strong retail sales data and positive investor sentiment. However, the index quickly fell from grace following U.S. President-elect Donald Trump’s announ...

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!

The CO2 markets and emissions trading are among the few winners of the climate conference in Baku. The dynaCERT share should benefit, as the technology company could face a surge of orders in 2025, potentially leading to a revaluation of the stock. Siemens Energy has rece...

From now on, dynaCERT instead of Bitcoin or NVIDIA?

While Bitcoin and NVIDIA dominate the headlines and investors hope for the next rally, a promising opportunity is emerging with dynaCERT Inc. (ISIN: CA26780A1084 | Ticker-TSX: DYA) for those seeking a true growth story. Read on to learn why this Canadian company may now b...

Here are three global stocks you should watch

Taking a macro or global view on stocks can be educational and offer a different view on the economy. Alpha Ba , portfolio manager specializing in global and emerging markets equities with Pillow Investments , gives us his three global stock picks. The three stock ...
1 2 3 4 5 6 7 8 9 10 ...